Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Molluscum Contagiosum (MC) Treatment Market Grown from 2024 to 2025?
The molluscum contagiosum (MC) treatment market has seen robust growth in the previous years. The estimated rise will be from $2.93 billion in 2024 to $3.11 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.2%. The growth in the historical period can be attributed to factors such as the growing awareness about skin infections and respective treatments, an upturn in pediatric cases, expansion in healthcare expenditure, an increase in the count of immunocompromised individuals, and higher funding from private and governmental entities.
What Growth Rate Is Anticipated for the Molluscum Contagiosum (MC) Treatment Market in the Coming Years?
Anticipations are high for the molluscum contagiosum (MC) treatment market to exhibit robust growth in the coming years, reaching an impressive $3.89 billion by the year 2029 with a compound annual growth rate (CAGR) of 5.8%. The rise throughout the forecast period can be traced back to a growing inclination towards non-invasive procedures, an escalating incidence of skin conditions, amplified healthcare demand, an increased prevalence of chronic illnesses, and the growing accessibility of sophisticated treatment options. Key trends expected throughout the forecast period encompass a gravitation towards cosmetic treatments, the progression of topical delivery systems, a transition towards home-based treatments, advancements in cryotherapy, and an emphasis on pediatric treatment choices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21225&type=smp
Who Are the Leading Companies in the Molluscum Contagiosum (MC) Treatment Market?
Major companies operating in the molluscum contagiosum (MC) treatment market are Verrica Pharmaceuticals, Novan Inc., Veloce BioPharma LLC, Gurina Foundation, Competition Deep Dive, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis, Ligand Pharmaceuticals Incorporated, Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Nielsen BioSciences Inc., MedCara Pharmaceuticals LLC, Gurina Foundation, Veloce BioPharma LLC, Labo ACM
What Are the Key Drivers of the Molluscum Contagiosum (MC) Treatment Market?
The growing preference for less harmful treatments is projected to fuel the expansion of the molluscum contagiosum treatment market. These treatments cause minor disruption to the body, typically via small or non-existent incisions. The popularity of these treatments is due to their potential to decrease recovery periods, reduce surgical complications, and improve patient results compared to conventional approaches. Cryotherapy and laser therapy are minimally invasive techniques used for molluscum contagiosum treatment, resulting in efficient removal, less recuperation time, and minimal scarring. The occasional, widespread lesions in molluscum contagiosum are best handled by these treatments which usually involve fewer appointments. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a non-profit organization in the US, claimed that in 2023, 83% of all medical procedures – that is, 35 million – were minimally invasive, leaving only 17% as traditional surgical procedures. Thus, the mounting interest in minimally invasive treatments is steering the growth of the molluscum contagiosum treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21225&type=smp
What Are the Key Market Segments in the Molluscum Contagiosum (MC) Treatment Industry?
The molluscum contagiosum (MC) treatment market covered in this report is segmented –
1) By Type: Molluscum Contagiosum Virus (MCV) -1, Molluscum Contagiosum Virus (MCV) -2, Molluscum Contagiosum Virus (MCV) -3, Molluscum Contagiosum Virus (MCV) -4
2) By Treatment Type: Topical Therapy, Immune-Modulators And Procedural Treatments
3) By Route Of Administration: Topical, Oral
4) By End User: Hospitals, Dermatology Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Molluscum Contagiosum Virus (MCV) -1: Topical Treatments, Cryotherapy, Curettage
2) By Molluscum Contagiosum Virus (MCV) -2: Topical Treatments, Cryotherapy, Curettage
3) By Molluscum Contagiosum Virus (MCV) -3: Topical Treatments, Cryotherapy, Curettage
4) By Molluscum Contagiosum Virus (MCV) -4: Topical Treatments, Cryotherapy, Curettage
What Are the Latest Trends in the Molluscum Contagiosum (MC) Treatment Market?
Key players in the molluscum contagiosum (MC) treatment market are prioritizing the creation of novel products, like topical gels, to maximize effectiveness, ensure patient adherence, and offer non-invasive treatment alternatives. Topical gels are semi-solid mediums applied to skin or mucous membranes for targeted treatment or medical benefits. For example, in April 2024, US-based biopharmaceutical firm Ligand Pharmaceuticals Incorporated introduced Pelthos Therapeutics to market Zelsuvmi (brazier) topical gel, 10.3% – marking the first Food and Drug Administration-approved at-home MC treatment for kids and adults over one-year-old. This gel, which releases nitric oxide, disrupts viral replication and aids in lesion clearance. Zelsuvmi provides a non-invasive, pain-free substitute for traditional, in-office procedures like cryotherapy or curettage, hence being a feasible and user-friendly treatment choice for patients aged one year or higher.
Access The Full Report Here:
What Are the Key Regional Markets in the Molluscum Contagiosum (MC) Treatment Industry?
North America was the largest region in the molluscum contagiosum (MC) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molluscum contagiosum (MC) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21225
This Report Delivers Insight On:
1. How big is the molluscum contagiosum (mc) treatment market, and how is it changing globally?
2. Who are the major companies in the molluscum contagiosum (mc) treatment market, and how are they performing?
3. What are the key opportunities and risks in the molluscum contagiosum (mc) treatment market right now?
4. Which products or customer segments are growing the most in the molluscum contagiosum (mc) treatment market?
5. What factors are helping or slowing down the growth of the molluscum contagiosum (mc) treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model